Sugi Predict

Sugi Predict / Compounds / SCHEMBL6055087

SCHEMBL6055087

SCHEMBL6055087

CCCCC(O)c1cccc(C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ PSEN1 P49768 1/20 0.43
▸ PSEN2 P49810 1/20 0.43
▸ APH1B Q8WW43 1/20 0.43
▸ NCSTN Q92542 1/20 0.43
▸ APH1A Q96BI3 1/20 0.43
▸ PSENEN Q9NZ42 1/20 0.43
▸ LMNA P02545 3/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ HIF1A Q16665 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ GMNN O75496 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9796230 0.95 MAPK1 (0.46) ALDH1A1LMNAMAPK1HIF1ATP53
SCHEMBL9796300 0.93 MAPK1 (0.45) ALDH1A1LMNAMAPK1HIF1ATP53
SCHEMBL14402512 0.91 TAS1R3 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13849155 0.91 TAS1R3 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6055393 0.91 TAS1R3 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13850017 0.91 TAS1R3 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL23347548 0.84 PSEN1 (0.40) ALDH1A1KDM4EPSEN1PSEN2APH1B
SCHEMBL20996730 0.84 MAPK1 (0.42) ALDH1A1LMNAMAPK1HIF1ATP53
SCHEMBL17277404 0.84 HTR2A (0.46) HIF1ACYP3A4CYP2C9TSHRNFKB1
SCHEMBL6871752 0.84 ACP3 (0.40) KDM4ELMNAHIF1ATSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111218160-B Electronic ink, preparation method and application thereof, and preparation method of quantum dot light-emitting device 广东聚华印刷显示技术有限公司 2022-07-12 — — CN claimed
CN-110144139-B Zinc oxide-based nanoparticle ink and photoelectric device 纳晶科技股份有限公司 2022-01-18 — — CN claimed
CN-111876021-A Ink composition, preparation method thereof and quantum dot light-emitting device 广东聚华印刷显示技术有限公司 2020-11-03 — — CN claimed
CN-111218160-A Electronic ink, preparation method and application thereof, and preparation method of quantum dot light-emitting device 广东聚华印刷显示技术有限公司 2020-06-02 — — CN claimed
CN-111218157-A Quantum dot electronic ink and preparation method thereof 广东聚华印刷显示技术有限公司 2020-06-02 — — CN claimed
CN-111883674-B Quantum dot light emitting diode and preparation method thereof 广东聚华印刷显示技术有限公司 2023-07-28 — — CN disclosed
CN-111218160-B Electronic ink, preparation method and application thereof, and preparation method of quantum dot light-emitting device 广东聚华印刷显示技术有限公司 2022-07-12 — — CN disclosed
CN-110144139-B Zinc oxide-based nanoparticle ink and photoelectric device 纳晶科技股份有限公司 2022-01-18 — — CN disclosed
CN-111876021-A Ink composition, preparation method thereof and quantum dot light-emitting device 广东聚华印刷显示技术有限公司 2020-11-03 — — CN disclosed
CN-111883674-A Quantum dot light-emitting diode and preparation method thereof 广东聚华印刷显示技术有限公司 2020-11-03 — — CN disclosed
CN-111218160-A Electronic ink, preparation method and application thereof, and preparation method of quantum dot light-emitting device 广东聚华印刷显示技术有限公司 2020-06-02 — — CN disclosed
CN-111218157-A Quantum dot electronic ink and preparation method thereof 广东聚华印刷显示技术有限公司 2020-06-02 — — CN disclosed
EP-1300381-A1 Process for preparing optically active alcohols Japan Science and Technology Corporation (JP) 2003-04-09 — — EP disclosed
US-20020144360-A1 Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors FIRMENICH SA (CH) 2002-10-10 — — US disclosed
US-6184381-B1 USEFUL AS INTERMEDIATES FOR SYNTHESIZING PHARMACEUTICAL CHEMICALS, LIQUID CRYSTAL MATERIALS AND AGENTS FOR OPTICAL RESOLUTION, REDUCTION, KETONES TO ALCOHOL, IMINES TO AMINES JAPAN SCIENCE & TECHNOLOGY CORP. (JP) 2001-02-06 — — US disclosed
EP-0916637-A1 PROCESS FOR PREPARATING OPTICALLY ACTIVE COMPOUNDS Japan Science and Technology Corporation (JP) 1999-05-19 — — EP disclosed
US-5006534-A Substituted ethers, thioethers and amines for use as lipoxygenase inhibitors BAYER AKTIENGESELLSCHAFT (DE) 1991-04-09 — — US disclosed
EP-0224086-B1 SUBSTITUTED BENZYL ETHERS BAYER AG (DE) 1990-10-24 — — EP disclosed
EP-0224086-A2 Substituted benzyl ethers BAYER AG (DE) 1987-06-03 — — EP disclosed
EP-0009540-A2 Fragrance compositions INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1980-04-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020144360-A1 Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors ADH1C, ADH1A, CBR1 ALDH1A1 72/4885KDM4E 1085/4885PSEN1 4410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.